RFS
ALNY icon

Richardson Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Richardson Financial Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5
Closed -$1.63K – 516
2025
Q2 		$1.63K Hold
5
– – ﹤0.01% 488
2025
Q1 		$1.35K Sell
5
-2
-29% -$514 ﹤0.01% 493
2024
Q4 		$1.65K Sell
7
-3
-30% -$789 ﹤0.01% 492
2024
Q3 		$2.59K Buy
10
+5
+100% +$1.3K ﹤0.01% 482
2024
Q2 		$1.22K Sell
5
-5
-50% -$789 ﹤0.01% 490
2024
Q1 		$1.94K Buy
+10
New +$1.67K ﹤0.01% 507

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Richardson Financial Services's ALNY Position: Q3 2025 in Review

Richardson Financial Services sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2025, closing a stake of 5 shares — an estimated $1.63K sold.

Richardson Financial Services first reported a position in ALNY in Q1 2024 and held it in 6 quarters. The position peaked at $2.59K in Q3 2024. 823 funds tracked by Wall St. Rank hold ALNY as of Q3 2025.

  • Richardson Financial Services reported no remaining Alnylam Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Richardson Financial Services sold 5 Alnylam Pharmaceuticals shares in Q3 2025, an estimated $1.63K.
  • Richardson Financial Services first reported a position in Alnylam Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • Richardson Financial Services's Alnylam Pharmaceuticals position peaked at $2.59K in Q3 2024.
  • 823 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2025.

Based on Richardson Financial Services's 13F filing for Q3 2025, filed 28 Oct 2025.